Comparison of FRETS-VWF73 to full-length VWF as a substrate for ADAMTS13 activity measurement in human plasma samples [6]

Thrombosis and Haemostasis

Volumn 95, Issue 6, 2006, Pages 1049-1051

  Mahdian, Reza ^a   Rayes, Julie ^a   Girma, Jean Pierre ^a   Houllier, Anne ^a   Obert, Bernadette ^a   Meyer, Dominique ^a   Veyradier, Agnès ^a  

^a Dept Environ Med Natl Inst Publ HIth   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

AMINO ACID ANALYSIS; BLOOD ANALYSIS; BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNORADIOMETRIC ASSAY; INCUBATION TIME; INTERMETHOD COMPARISON; LETTER; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SPECTROFLUOROMETRY; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNORADIOMETRIC ASSAY; PEPTIDE FRAGMENTS; PURPURA, THROMBOCYTOPENIC; REPRODUCIBILITY OF RESULTS; VON WILLEBRAND FACTOR;

EID: 33745313730     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-03-0166     Document Type: Letter

References (11)

1. Moake JL, Rudy CK, Troll JH, et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982; 307: 1432-5.
2. Plaimauer B, Zimmermann K, Volkel D, et al. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13). Blood 2002; 100: 3626-32.
3. Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 488-94.
4. Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578-84.
5. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-94.
6. Kokame K, Matsumoto M, Fujimura Y, et al. VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood 2004; 103: 607-12.
7. Kokame K, Nobe Y, Kokubo Y, et al. FRETSVWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 2005; 129: 93-100.
8. Groot E, Hulstein JJ, Rison CN, et al. FRETSVWF73: a rapid and predictive tool for thrombotic thrombocytopenic purpura. J Thromb Haemost 2006; 4: 698-9.
9. Obert B, Tout H, Veyradier A, et al. Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF. Thromb Haemost 1999; 82: 1382-5.
10. George JN. ADAMTS13, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome. Curr Hematol Rep 2005; 4: 167-9.
11. Sadler JE, Moake JL, Miyata T, et al. Recent advances in thrombotic thrombocytopenic purpura. Hematology 2004 (Am Soc Hematol Educ Program); 407-23.